SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Sep 24, 2018
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: Sept. 24, 2018 · CIK: 0001585608 · Accession: 0000000000-18-030006
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227292
Letter
September 24, 2018 Lisa A. Conte Chief Executive Officer and President Jaguar Health, Inc. 201 Mission Street, Suite 2375 San Francisco, CA 94105 Re:Jaguar Health, Inc. Registration Statement on Form S-1 Filed September 12, 2018 File No. 333-227292 Dear Ms. Conte: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jeffrey Gabor at 202-551-2544 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Donald C. Reinke, Esq.
Show Raw Text
September 24, 2018
Lisa A. Conte
Chief Executive Officer and President
Jaguar Health, Inc.
201 Mission Street, Suite 2375
San Francisco, CA 94105
Re:Jaguar Health, Inc.
Registration Statement on Form S-1
Filed September 12, 2018
File No. 333-227292
Dear Ms. Conte:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jeffrey Gabor at 202-551-2544 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Donald C. Reinke, Esq.